Premium
Letter: addition of methotrexate neither restores clinical response nor improves the pharmacokinetic profile of vedolizumab‐treated patients
Author(s) -
Gouynou C.,
PeyrinBiroulet L.
Publication year - 2017
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.14320
Subject(s) - vedolizumab , medicine , methotrexate , pharmacokinetics , pharmacology , ulcerative colitis , disease